File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials

TitleQuality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials
Authors
Xiao, Y.Yin, F.Kong, F. M.S.Yue, J.Galvin, J.
Keywordsquality
Surgery
SBRT
NSCLC
clinical trials
Issue Date2013
Citation
IFMBE Proceedings, 2013, v. 39 IFMBE, p. 2284-2287 How to Cite?
DOI: http://dx.doi.org/10.1007/978-3-642-29305-4_599
AbstractClinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies. © 2013 Springer-Verlag.
Persistent Identifierhttp://hdl.handle.net/10722/266958
ISSN
1680-0737
2023 SCImago Journal Rankings: 0.137

 

DC FieldValueLanguage
dc.contributor.authorXiao, Y.-
dc.contributor.authorYin, F.-
dc.contributor.authorKong, F. M.S.-
dc.contributor.authorYue, J.-
dc.contributor.authorGalvin, J.-
dc.date.accessioned2019-01-31T07:20:05Z-
dc.date.available2019-01-31T07:20:05Z-
dc.date.issued2013-
dc.identifier.citationIFMBE Proceedings, 2013, v. 39 IFMBE, p. 2284-2287-
dc.identifier.issn1680-0737-
dc.identifier.urihttp://hdl.handle.net/10722/266958-
dc.description.abstractClinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies. © 2013 Springer-Verlag.-
dc.languageeng-
dc.relation.ispartofIFMBE Proceedings-
dc.subjectquality-
dc.subjectSurgery-
dc.subjectSBRT-
dc.subjectNSCLC-
dc.subjectclinical trials-
dc.titleQuality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials-
dc.typeConference_Paper-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/978-3-642-29305-4_599-
dc.identifier.scopuseid_2-s2.0-84876020076-
dc.identifier.volume39 IFMBE-
dc.identifier.spage2284-
dc.identifier.epage2287-
dc.identifier.issnl1680-0737-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats